Quoin Pharmaceuticals, Ltd. (QNRX)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20261 patent granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Quoin Pharmaceuticals, Ltd.’s names, not what it holds today.
1 published
2 published
1 published
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| May 7, 2013 | 8,435,786 | Methods of selecting stem cells and uses thereof | Biotechnology | Cellect Biotechnology Ltd. |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Aug 1, 2024 | 2024/0252465 | COMBINATION TREATMENT FOR NETHERTON SYNDROME | Pharmaceuticals | Quoin Pharmaceuticals Inc. |
| Feb 12, 2015 | 2015/0044182 | DEVICES AND METHODS FOR SELECTING APOPTOSIS-SIGNALING RESISTANT CELLS, AND USES THEREOF | Pharmaceuticals | Cellect Biotechnology Ltd. · patent 9,783,778 granted from it |
| Oct 31, 2013 | 2013/0287750 | METHOD OF SELECTING STEM CELLS AND USES THEREOF | Biotechnology | Cellect Biotechnology Ltd. |
| May 23, 2013 | 2013/0129771 | REGULATORY IMMUNE CELLS WITH ENHANCED TARGETED CELL DEATH EFFECT | Medical technology | Cellect Biotechnology Ltd. · patent 9,624,469 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.